A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

PHASE3CompletedINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

September 30, 2006

Conditions
Macular Degeneration
Interventions
DRUG

rhuFab V2 (ranibizumab)

Trial Locations (82)

11570

Ophthalmic Consultants of Long Island, Rockville Centre

12208

Lions Eye Institute, Albany

15212

Allegheny General Hospital, Pittsburgh

17011

Pennsylvania Retina Specialists, Camp Hill

19107

Wills Eye Hospital, Philadelphia

21401

Retina Associates PC, Annapolis

22031

Retina Group of Washington, Fairfax

22710

Duke Univ Medical Center/Duke Eye Center, Durham

28210

Southeast Clinical Research, Charlotte

28803

Western Carolina Retinal Associates, PA, Asheville

29204

Palmetto Retina Center, Columbia

29414

Retina Consultants of Charleston, Charleston

30322

Emory University, Atlanta

30912

Medical College of Georgia, Augusta

32114

Florida Retina Institute, Daytona Beach

32308

Southern Vitreoretinal Associates PA, Tallahassee

32806

Central Florida Retina, Orlando

33063

Retina Associates of South Florida, Margate

33136

Bascom Palmer Eye Institute, Miami

33334

Retina Vitreous Consultants, Fort Lauderdale

33410

Retina Care Specialists, Palm Beach Gardens

33418

Bascom Palmer Eye Institute, Palm Beach Gardens

33612

University of South Florida, Tampa

33901

Retina Consultants of Southwest Florida, Fort Myers

Retina Health Center, Fort Myers

34239

Ophthalmic Consultants, Sarasota

37203

Retina Vitreous Associates, Nashville

37909

Southeastern Retina Associates, P.C., Knoxville

43215

Midwest Retina, Columbus

43608

Retina Vitreous Associates, Toledo

44122

Retina Associates of Cleveland, Beachwood

44195

Cleveland Clinic Foundation/Cole Eye Institute, Cleveland

45242

Flavio Company, Cincinnati

46280

Thomas A. Ciulla, MD, PC, Indianapolis

48034

Retina Consultants of Michigan, Southfield

48073

Associated Retinal Consultants, P.C., Royal Oak

48105

University of Michigan, Ann Arbor

49546

Associated Retinal Consultants, Grand Rapids

53226

Medical College of Wisconsin, Milwaukee

57701

BH Regional Eye Institute, Rapid City

63031

Retina Associates of St. Louis, Florissant

63104

St. Louis University Eye Institute, St Louis

66160

University of Kansas Medical Center, Kansas City

73120

Retinal Associates of Oklahoma, Oklahoma City

75115

Retina Specialists, DeSoto

77030

Vitreoretinal Consultants, Houston

77555

UTMB, Galveston

78229

Univ of Texas Health Science Center, San Antonio

78240

Medical Center Ophthalmology, San Antonio

78503

Valley Retina Institute, P.A., McAllen

78705

Austin Retina Associates, Austin

Brian Berger, MD P.A., Austin

84107

Rocky Mountain Retina Consultants, Salt Lake City

84132

John Moran Eye Center/Univ of Utah, Salt Lake City

85704

Retina Centers, P.C., Tucson

85711

University of Arizona, Tucson

90033

Doheny Eye Institute, Los Angeles

90211

Retina-Vitreous Associates Medical Group, Beverly Hills

92697

UC Irvine, Irvine

94025

California Vitreoretinal Research Center, Menlo Park

94040

No. California Retina-Vitreous Associates, Mountain View

94143

UCSF School of Medicine, San Francisco

97520

Retina & Vitreous Center of So. Oregon, Ashland

98104

Vitreoretinal Associates, Seattle

06810

Danbury Eye Physicians & Surgeons, Danbury

06518

New England Retina Associates, Hamden

02111

New England Eye Center, Boston

02114

Center for Eye Research, Boston

01089

New England Retina Consultants, West Springfield

08648

Delaware Valley Retina Associates, Lawrenceville

VIC-3002

University of Melbourne, Department of Ophthalmology, East Melbourne

NSW 2150

Marsden Eye Research Pty Ltd, Parramatta

NSW-2000

Save Sight Institute, Sydney

NSW-2145

Westmead Hospital, Westmead

100 00

Onci klinika FNKV, Prague

F-94010

Clinique d'Ophtalmologie, Créteil

F-13008

Clinique Monticelli, Marseille

F-75475

Hôpital Lariboisière, Paris

D-53105

Universitätsklinikum Bonn, Bonn

D-50924

Universitatskliniken Koln, Cologne

D-04103

Universitätsklinikum Leipzig, Leipzig

H-1083

Semmelweis University, 1st Ophthalmological Department, Budapest

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00061594 - A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration | Biotech Hunter | Biotech Hunter